Can dapagliflozin have a protective effect against COVID-19 infection? A hypothesis

Diabetes is a risk factor for the progression and prognosis of <scp>COVID</scp>‐19

Weina Guo, Mingyue Li, Yalan Dong et al. · Diabetes/Metabolism Research and Reviews · 2020 · 1.4K citations · Full text

Hydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase

Chad Vickers, Paul Hales, Virendar K. Kaushik et al. · Journal of Biological Chemistry · 2002 · 1.4K citations · Full text

COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism

Wenzhong Liu, Li hualan · 2020 · 252 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Immunology +19

Effects of the SGLT‐2 inhibitor dapagliflozin on glomerular and tubular injury markers

Claire C. J. Dekkers, S. Petrykiv, Gozewijn D. Laverman et al. · Diabetes Obesity and Metabolism · 2018 · 250 citations · Full text

Hemodynamic consequences of severe lactic acidosis in shock states: from bench to bedside

Antoine Kimmoun, Emmanuel Novy, Thomas Auchet et al. · Critical Care · 2015 · 196 citations · Full text